Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
The main purpose of this study is to determine which is the best dose of a drug known as
Dysport to give when treating one's type of upper back pain. The study will also examine the
side effects of this treatment and its overall effect on one's disorder.
Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome
The main purpose of this study is to determine the effectiveness and safety of one dose of
botulinum toxin type A (Dysport) associated with rehabilitation treatment on pain control in
patients with a type of back pain called primary myofascial pain syndrome.
NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder
University Hospital, Rouen
The purpose of this study is to determine the efficacy and tolerance of 2 dosages (750
versus 500 units) of the Dysport type A botulinic toxin for patient suffering from
neurogenic urinary incontinence by an overactive bladder and the failure of anticholinergic
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.